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INTRODUCTION
The term "reproductive biotechnology" has different meanings in different circumstances. 
I will use a broad definition that ranges from estrus synchronization to DNA manipulation.  By
far the most relevant and important reproductive biotechnology for beef cattle production is
artificial insemination.  It is shocking that only around 5% of calves of beef cattle breeds in this
country are sired via this biotechnology, but I will not discuss artificial insemination further
because the methodology, costs, and applications are well known.  In my opinion, the second
most important reproductive biotechnology is estrous cycle synchronization; I'll not cover this
further because there will be an entire paper devoted to it in this symposium.  An important third
reproductive biotechnology, ultrasound, also will be covered by another speaker.
Over the next decade, all other reproductive technologies added together will not sum up
to the importance of artificial insemination plus estrus synchronization.  In fact, most other
reproductive biotechnologies currently are completely inappropriate for most beef cattle
operations.  On the other hand, there will be profitable but specialized niches in some operations
for application of nearly all of the biotechnologies that I will describe.
EMBRYO TRANSFER
Probably 45,000 to 50,000 calves of beef cattle breeds are born as a result of embryo
transfer each year in the United States, or about 1 out of every 700 to 800 calves.  The main
application is to amplify the reproductive rates of valuable cows so offspring can be sold or used
for breeding purposes.  Other applications include changing from grade to registered herds,
circumventing infertility, exporting embryos, and genetic testing.  This technology is integral for
the use of most other biotechnologies to be described later.
Variability of embryo production from individual donors is extreme; with good
management, about 25% of donors produce no pregnancies; the average embryo production per
donor is about 6 useable embryos, and the mean number of pregnancies per donor is just over 3
(Table 1).  However, many assumptions are associated with such data.  With excellent
management and use of heifers as recipients, pregnancy rates may exceed 70% with unfrozen
embryos.  However, for a variety of reasons, pregnancy rates frequently are less than 50% per
embryo transferred.
Table 1.  Distribution of Numbers of Pregnancies from 64 Superovulated Donors





0 14 22 0
1-2 16 25 11
3-4 16 25 26
5-7 11 18 31
8-10 4 7 16
11+ 3 5 15
Successful embryo transfer programs require attention to detail, and usually cost some
hundreds to more than $1,000 per calf produced, over and above conventional costs of producing
calves.  With the right market, this can be very profitable, but if conditions are inappropriate, it is
easy to lose money.  It is highly recommended that a successful artificial insemination program
be in place (including personnel, feed, facilities, and cattle) before embryo transfer is attempted.
CRYOPRESERVATION OF EMBRYOS
This biotechnology has become an integral part of embryo transfer technology because it
increases flexibility enormously.  It takes somewhat more than 1 hour to freeze a batch of
embryos, and around 20 minutes to thaw embryos and remove cryoprotectants.  The main use is
in freezing excess embryos when more are produced than the number of recipients available at
the right stage of the estrous cycle; conversely, embryos can be thawed when there is an excess of
available recipients.  In fact, one can decouple the embryo collection and embryo transfer
processes entirely with this biotechnology.  This is especially useful when donors are not at the
desired stage of the annual reproductive cycle (usually 60-90 days post-partum) when the
potential recipients are.  There also are the obvious options of using distant donors, even
importing and exporting embryos.  There is a special advantage to moving germ plasm via
embryos because the danger of spreading disease is much lower than with animals or semen. 
Special precautions such as extra rinsing are taken when freezing embryos for export purposes,
and these depend on the importing country, so plans must be made beforehand.  Whether for
domestic or export sale, embryos represent an additional commodity for a beef stock producer. 
In some countries, frozen embryos provide a practical method for twin production.  In most
cases, embryo transfer procedures are too expensive for this to be profitable in the United States.
The major cost of freezing embryos is that pregnancy rates are reduced 10-15% with high
quality embryos, and are still lower with embryos of marginal quality; thus, the latter type rarely
are frozen.  These costs are, however, recouped due to lower recipient needs, which reduces feed
and management costs.  In many cases, the most profitable strategy is to have recipients available
for most embryos and to freeze the excess, thereby taking advantage of the higher pregnancy
rates with fresh embryos, and saving costs of preparing recipients that will not be used if embryo
production is low.  A minor cost of frozen embryos is the freezing and thawing process itself. 
This plus costs of equipment, liquid nitrogen, etc. is $10 to $50 per embryo under most
circumstances.  Over half of the embryos collected in this country are frozen, which illustrates
the current utility of this technology.
BISECTION OF EMBRYOS
Good to excellent quality embryos can literally be cut in half with microtools under a
microscope.  If both halves develop, identical twins are produced.  With good management and
personnel appropriately trained in microsurgery, the pregnancy rate per half embryo is around
50%.  Since two halves are produced, the net pregnancy rate would be 100% per original embryo. 
Usually each half embryo is transferred to a different recipient to avoid problems that sometimes
occur with twin pregnancies.  Of course, the two halves can be placed in the same recipient
without danger of producing freemartins since both halves will be of the same sex.  With a 50%
pregnancy rate per half embryo, identical twins occur for ¼ of the embryos, single pregnancies
for ½ of the embryos, and no pregnancy for ¼ of the embryos.  Success rates decrease markedly
when embryos are divided into 3 or more pieces.
This technique is especially valuable when only one or two embryos are recovered from a
valuable donor.  Thousands of calves have been produced with these methods.  There are no
more abnormalities with calves resulting from bisected embryos than from artificial insemination
without embryo transfer.  Even though these procedures work, probably fewer than 1,000 calves
per year result from this procedure.  The reasons that this is not used more seem to be:  1) Only a
few embryo transfer practitioners have the training and equipment for such work; 2) bisected
embryos have low pregnancy rates after freezing; and 3) the procedures take 20-30 minutes per
embryo (with setup time) and thus disrupt the flow of work.  The costs are under $50 per embryo
bisected under most circumstances.
SEXING EMBRYOS
There are several methods of sexing embryos, and one is available commercially.  This
technique requires removal of a few cells of the embryo, using techniques similar to those for
bisecting embryos.  The genetic material (DNA) is extracted from these cells, and millions of
copies of a small segment of DNA on the Y-chromosome (if there is a Y-chromosome) are
produced by a technique called the polymerase chain reaction.  A test then determines whether
this part of the Y-chromosome is present (male) or absent (female).  The whole procedure takes
several hours.  About 85% of bovine embryos are sexable with this approach in skilled hands,
and the accuracy is over 95%.  Thus, one gets about 43% males, 42% females, and 15% of
unknown sex, with few mistakes for those that are designated males or females.
Surprisingly, this technology has not really caught on.  Only a few thousand embryos are
sexed annually in the United States.  This may be due to the lack of trained people and the extra
time and expense required.  The cost of sexing often is around $100/embryo, but if only one sex
is worth transferring, the cost is closer to $400 extra per pregnancy because half of the embryos
would be discarded, and just over half of the remainder would develop to term.
For most beef cattle donors, calves of both sexes are valuable, so there is little point in
sexing because all embryos would be transferred anyway.  If the objective is just to get
information about sex, this can be done more easily and cheaply with ultrasound at about 60 days
of gestation.  In some cases, costs of embryo transfer would be justified by calves of one sex, but
not the other.  But at $400 extra per correctly sexed pregnancy, this approach must be examined
carefully.  Sexing embryos will be used more and more as this technology becomes simpler and
less expensive.  Eventually, however, it will be replaced entirely with sexed semen.
SEXING SEMEN
There is no commercially available method for sexing semen, but there is a method that
works under laboratory conditions.  X-chromosome-bearing bull sperm (which lead to females)
have about 4% more DNA than Y-chromosome-bearing ones (which lead to males).  By placing
sperm in a solution of DNA-binding dye, X-chromosome-bearing sperm become more brightly
stained than Y-chromosome-bearing sperm.  By use of lasers plus a device called a cell sorter, it
is possible to separate the sperm into three test tubes, male, female, and unsexable (the great
majority).  Those in the sexed test tubes accumulate at about 1,000 sperm per second, with an
accuracy of just over 80%.
Although 500 sperm per second of each sex is phenomenally rapid, in reality it is too
slow to be practical for most purposes.  For example, one straw of semen often contains 50
million sperm (30 million motile before freezing).  At 500 sperm per second, it would take
100,000 seconds per straw or more than 24 hours to produce 1 dose of semen.  The logistics of
keeping sperm viable for such lengths of time at room temperature are considerable.  The
equipment is very expensive (over $50,000 per setup) and complicated to operate.  Fertility
probably would be lowered somewhat, and the long-term consequences of adding dye to DNA
are unknown.  However, procedures for sexing sperm likely will improve markedly over the next
few years, and one practical application, use of such sperm with in vitro fertilization (which
requires few sperm), may not be far off.
 IN VITRO FERTILIZATION
In vitro fertilization consists of four steps:  1) preparing the sperm (termed capacitation),
2) maturing the unfertilized eggs (oocytes), 3) placing the sperm and oocytes together for
fertilization, and 4) keeping the embryos in an incubator for 5-6 additional days while they
develop through 2-cell, 4-cell stages, etc. and become suitable for freezing or embryo transfer.  I
will not explain the technical details of these steps, but point out that they require great attention
to detail for over 1 week, and cannot be done practically on the farm.
The main application of in vitro fertilization is to circumvent infertility, much as it is used
in women.  A related application is to obtain more pregnancies than otherwise possible in cows
that do not respond to superovulation.  A third application is to obtain calves by recovering
oocytes from cows near death or even a few hours after death.  In fact, for experimental purposes,
we routinely obtain ovaries from slaughterhouses and recover the oocytes up to 6 hours after
slaughter.
Oocytes are recovered from living cows by aspirating follicles on the ovaries through a
long needle inserted into the body cavity through the wall of the vagina.  The needle is guided
precisely by using an ultrasound machine to visualize the needle and the ovary.  The donor cow
need not be injected with hormones to stimulate follicular growth; the oocytes are matured in
vitro anyway.  All follicles readily visualized (usually those 3 mm or more in diameter) are
aspirated, generally resulting in 10 or more oocytes per pair of ovaries.  Usually, nearly half are
abnormal and discarded.  Typically 75% of oocytes become fertilized, 35% of these develop
normally to the late morula or blastocyst stage, and pregnancy rates are 40%.  Multiplying 50%
normal x 75% fertilized x 35% developing normally x 40% pregnancy yields a net pregnancy rate
of 4.9% per oocyte aspirated, or about ½ pregnancy per try.  However, this can be repeated
weekly, which results in an average of two pregnancies per month.  This has been repeated with
some cows for more than 1 year, though typically breeders stop after 10-15 pregnancies.
Five or six companies with reasonably documented success offer this service in the
United States.  Typically they charge $500 per pregnancy more than with conventional embryo
transfer procedures.  Usually three technicians are required to make this work well.  Probably
over 1,000 calves will be produced by these methods in 1993.  In the future, in vitro fertilization
will be combined with sexed semen to produce sexed pregnancies.
CLONING BY NUCLEAR TRANSPLANTATION
The objective of this technology is to produce large numbers of genetically identical
animals (clones).  Most of the cells in a 32-cell (or earlier stage) embryo contain a totipotent
nucleus, which means that if the nucleus of one of these cells is transplanted to an oocyte, a
genetic copy results that can result in a calf (32 identical calves if all nuclei are used and
everything goes perfectly).  As the embryo develops to more cells, most cells become so
specialized that they are no longer totipotent, and therefore, will not produce a calf.  Probably 20-
30 cells remain totipotent, even in a 200-cell embryo.  Eventually most (all?) of these cells
probably lose totipotency.  With this technique, one is essentially fertilizing an oocyte with a
diploid nucleus (one that already has male and female genetic components) rather than a haploid
sperm.  With nuclear transplantation, the female genetic material in the oocyte is removed first
because the nucleus from the embryo already has both male and female genes.  With this
technology, one can make clonal copies of embryos, but not adults.
Unfortunately, only pedigree information is available concerning performance of the 
resulting calves before they are born.  Although the set of calves will be genetically identical with
each other, it is possible that they all will be mediocre phenotypically due to the vagaries of
animal breeding.  One solution to this problem is to freeze some of the embryos produced, and
allow only a few to develop into calves initially.  If they turn out to be excellent animals, genetic
copies can be made from the frozen identicals.  One can theoretically make an infinite number of
copies by serial nuclear transplantation, that is when the copies reach the 32-cell stage the whole
set of nuclei can be retransplanted into oocytes.
This technology currently is not available commercially, even though over 1,000 calves
have been produced.  There are two major problems.  The first is that success rates are low. 
Theoretically, one could get 32 embryos developing from transplanting nuclei from a 32-cell
embryo.  In practice, more like 5 or 6 develop on the average.  Also, pregnancy rates per
developing embryo are low, often around 20%.  Thus, one frequently only gets one calf from the
whole exercise.  Success rates are much higher for some embryos for unknown reasons, and with
serial nuclear transplantation, one might get 5 embryos the first round, 25 the second, 125 the
third, etc.  Even so, the largest set of identicals produced so far is eleven.
The second major problem is that many of the calves are abnormal at birth.  They tend to
be very slow to get up and nurse, become cold easily, and around 20% are larger than normal. 
Calves in the 130-140 lb range are common.  
The  reason for these problems is not known.  With excellent veterinary care, including
calving in a warm, dry area, and Caesarian section if calves are too big, death losses can be under
10%.  Out in the field, half of the cloned calves sometimes die.  Interestingly, if they survive, the
calves become fairly normal after a few days, and they do not have problems calving themselves
or transmit these problems to the next generation.  Thus, the problem is not genetic.  In the long
run, success rates with cloning by nuclear transplantation probably will increase markedly, and
the problem with abnormal calves probably will be solved.
DNA-BASED TECHNOLOGIES
A whole spectrum of technologies depends on the ability to distinguish DNA of one
animal from that of another.  The DNA can be obtained from blood or semen.  Broadly speaking,
the principles are similar to blood-typing, but DNA typing is much more powerful.  One example
is detection of deleterious recessive genes (a gene is a short, functional segment of DNA, that
usually provides the information for making a protein), such as bovine leucocyte adhesion
deficiency (BLAD), in carrier animals.  Another example is definitive paternity testing in
multiple sire mating pastures.  The techniques of marker-assisted selection also are based on
DNA typing; the procedure for sexing embryos described earlier is a special case of marker-
assisted selection.
A big advantage of DNA typing is being able to determine the genetic make-up of an
individual early (even as an embryo), and without breeding trials.  Knowing whether an
individual is homozygous or heterozygous for traits such as polled, black color, and normal
growth (not a dwarf carrier) will be very useful.  It is not yet possible to DNA type cattle for all
of these characteristics because of incomplete information about the DNA sequence of some of
these genes.  However, the requisite information is becoming available for more genes each year.
Several companies and university and government laboratories have provided DNA
typing services as a part of research and development projects.  However, these services have
been heavily subsidized.  The techniques of DNA typing require fairly technical procedures. 
Only a few companies and universities provide these services on a routine basis, and only for a
few applications.  Fees are likely to be in the $10-50 per sample range as this technology
matures; tests for additional traits on a particular blood or semen sample likely will be around $5-
10 per trait.  The key will be volume; 50,000 samples per year will be much more inexpensive
per sample than 5,000 per year.  It would seem that large scale paternity testing in multi-sire
breeding pastures, for example, would in most cases be difficult to justify if it a costs $10 or
more per animal in addition to costs of obtaining the blood.
TRANSGENIC ANIMALS
It is now possible to modify the genetic make-up of animals directly by adding, deleting,
or correcting genes in early embryos.  For example, one might add the polled trait to a particular
breed or line without changing other genes.  The DNA for transgenic procedures can even come
from other species.  For example, a growth gene might be added from a chicken, or a disease
resistance gene from an alligator.  While a handful of transgenic cattle have been made, this
biotechnology is so expensive and impractical that it may be 10 to 20 years before it is used
directly in beef cattle production.  However, transgenic procedures are very useful for certain
kinds of research, and the information from this research likely will be applied within the next
few years.
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